Literature DB >> 17466011

Phenotypic variability in 17beta-hydroxysteroid dehydrogenase-3 deficiency and diagnostic pitfalls.

Yung Seng Lee1, Jeremy M W Kirk, Richard G Stanhope, Derek I Johnston, Sharon Harland, Richard J Auchus, Stefan Andersson, Ieuan A Hughes.   

Abstract

OBJECTIVE: 17beta-hydroxysteroid dehydrogenase type 3 isoenzyme (17beta-HSD3) is required to produce testosterone for male sex differentiation. Mutations in the HSD17B3 gene cause 17betaHSD3 deficiency and result in XY sex reversal of varying degree. We report the phenotypes of 14 subjects with 17betaHSD3 deficiency in relation to sex of rearing, androgen production, and HSD17B3 mutations.
DESIGN: Cases were identified through the Cambridge Disorders of Sex Development Database where detailed clinical information was recorded, results of hCG stimulation tests were available, and HSD17B3 mutation was identified.
RESULTS: Fourteen subjects from seven pedigrees (four consanguineous) had the following seven mutations: A56T, N130S, E215D, S232L, C268Y, V205E, and a novel mutation M197K. XY sex reversal was classified as complete in 10 infants at birth. Inguinal masses suggestive of androgen insensitivity syndrome (AIS) occurred in five infants. Contrasexual virilization reminiscent of 5alpha-reductase deficiency occurred in four subjects at puberty. The median (range) testosterone : androstenedione (T/A) ratio after a short hCG stimulation test was 0.32 (0.12-3.4). The S232L mutation identified in three affected family members caused isolated, severe hypospadias in one member who was raised male; virilization occurred despite in vitro studies showing an inactive mutant enzyme. Ratios of T/A in this pedigree were more than 0.8.
CONCLUSION: XY sex reversal is sufficiently variable in 17betaHSD3 deficiency to cause problems in accurate diagnosis, particularly in distinguishing it from AIS. It should be considered in undervirilized male infants with normal Wolffian duct structures, absent Müllerian ducts, and normal adrenal steroid biosynthesis; or when an assigned female subject virilizes at puberty. Elevated hCG-stimulated T/A ratio may occur, and sex of rearing may not be concordant within affected families with the same HSD17B3 mutation. The T/A ratio, mutation analysis and functional analysis of the mutant enzyme taken in isolation, respectively, may not conclusively establish a diagnosis of 17betaHSD3 deficiency in undervirilized male subjects; the reasons for these discrepancies remain unknown.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17466011     DOI: 10.1111/j.1365-2265.2007.02829.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  21 in total

Review 1.  Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency.

Authors:  Lisal J Folsom; Mariam Hjaige; Jiayan Liu; Erica A Eugster; Richard J Auchus
Journal:  Mol Cell Endocrinol       Date:  2018-11-30       Impact factor: 4.102

2.  A Novel Mutation Causing 17-β-Hydroxysteroid Dehydrogenase Type 3 Deficiency in an Omani Child: First Case Report and Review of Literature.

Authors:  Aisha Al-Sinani; Waad-Allah S Mula-Abed; Manal Al-Kindi; Ghariba Al-Kusaibi; Hanan Al-Azkawi; Nahid Nahavandi
Journal:  Oman Med J       Date:  2015-03

3.  17beta-Hydroxysteroid dehydrogenase-3 deficiency: from pregnancy to adolescence.

Authors:  S Bertelloni; A Balsamo; L Giordani; R Fischetto; G Russo; M Delvecchio; M Gennari; A Nicoletti; M C Maggio; D Concolino; L Cavallo; A Cicognani; G Chiumello; O Hiort; G I Baroncelli; M F Faienza
Journal:  J Endocrinol Invest       Date:  2009-05-12       Impact factor: 4.256

Review 4.  Concepts and Updates in the Evaluation and Diagnosis of Common Disorders of Sexual Development.

Authors:  Amar Y Rawal; Paul F Austin
Journal:  Curr Urol Rep       Date:  2015-12       Impact factor: 3.092

Review 5.  [Progress on evaluation, diagnosis and management of disorders of sex development].

Authors:  Guangjie Chen; Xiaohao Wang; Daxing Tang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-06-25

Review 6.  Diagnosis of diseases of steroid hormone production, metabolism and action.

Authors:  John W Honour
Journal:  J Clin Res Pediatr Endocrinol       Date:  2009-08-02

7.  Concomitant mutations in the P450 oxidoreductase and androgen receptor genes presenting with 46,XY disordered sex development and androgenization at adrenarche.

Authors:  Jan Idkowiak; Ewa M Malunowicz; Vivek Dhir; Nicole Reisch; Maria Szarras-Czapnik; Donna M Holmes; Cedric H L Shackleton; John D Davies; Ieuan A Hughes; Nils Krone; Wiebke Arlt
Journal:  J Clin Endocrinol Metab       Date:  2010-04-21       Impact factor: 5.958

8.  Whole exome sequencing and functional characterization increase diagnostic yield in siblings with a 46, XY difference of sexual development (DSD).

Authors:  Sofia E Luna; Daniel J Wegner; Sarah Gale; Ping Yang; Abby Hollander; Lori St Dennis-Feezle; Zeina M Nabhan; Daniel S Ory; F Sessions Cole; Jennifer A Wambach
Journal:  J Steroid Biochem Mol Biol       Date:  2021-05-10       Impact factor: 5.011

9.  Complexities of gender assignment in 17β-hydroxysteroid dehydrogenase type 3 deficiency: is there a role for early orchiectomy?

Authors:  Janet Chuang; Amy Vallerie; Lesley Breech; Howard M Saal; Shumyle Alam; Peggy Crawford; Meilan M Rutter
Journal:  Int J Pediatr Endocrinol       Date:  2013-09-12

10.  The spectrum of phenotypes associated with mutations in steroidogenic factor 1 (SF-1, NR5A1, Ad4BP) includes severe penoscrotal hypospadias in 46,XY males without adrenal insufficiency.

Authors:  Birgit Köhler; Lin Lin; Inas Mazen; Cigdem Cetindag; Heike Biebermann; Ilker Akkurt; Rainer Rossi; Olaf Hiort; Annette Grüters; John C Achermann
Journal:  Eur J Endocrinol       Date:  2009-05-13       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.